Literature DB >> 31591098

Enteritis with immune checkpoint inhibitor use.

David Sanders1, Douglas Webber2, Nazira Chatur2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31591098      PMCID： PMC6779535          DOI： 10.1503/cmaj.190244

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Immune checkpoint inhibitor-induced gastrointestinal and hepatic injury: pathologists' perspective.

Authors:  Dipti M Karamchandani; Runjan Chetty
Journal:  J Clin Pathol       Date:  2018-04-27       Impact factor: 3.411

Review 2.  Adverse events associated with immune checkpoint inhibitor treatment for cancer.

Authors:  Khashayar Esfahani; Nicholas Meti; Wilson H Miller; Marie Hudson
Journal:  CMAJ       Date:  2019-01-14       Impact factor: 8.262

Review 3.  Enterocolitis due to immune checkpoint inhibitors: a systematic review.

Authors:  Emilie Soularue; Patricia Lepage; Caroline Robert; Franck Carbonnel; Jean Frederic Colombel; Clelia Coutzac; David Faleck; Lysiane Marthey; Michael Collins; Nathalie Chaput
Journal:  Gut       Date:  2018-08-21       Impact factor: 23.059

4.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

5.  Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma.

Authors:  Raymond H L Yip; Lawrence H Lee; David F Schaeffer; Basil A Horst; Hui-Min Yang
Journal:  Melanoma Res       Date:  2018-12       Impact factor: 3.599
  5 in total
  1 in total

1.  The Entire Intestinal Tract Surveillance Using Capsule Endoscopy after Immune Checkpoint Inhibitor Administration: A Prospective Observational Study.

Authors:  Keitaro Shimozaki; Kenro Hirata; Sara Horie; Akihiko Chida; Kai Tsugaru; Yukie Hayashi; Kenta Kawasaki; Ryoichi Miyanaga; Hideyuki Hayashi; Ryuichi Mizuno; Takeru Funakoshi; Naoki Hosoe; Yasuo Hamamoto; Takanori Kanai
Journal:  Diagnostics (Basel)       Date:  2021-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.